Assertio Therapeutics Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ASRT Nasdaq 2834 https://www.assertiotx.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Assertio Therapeutics Inc

Hedge Funds Are Crazy About Assertio Therapeutics, Inc. (ASRT) - Dec 13th, 2019 8:07 pm
Assertio to Divest Shingles Pain Drug to Alvogen for $127.5M - Dec 13th, 2019 1:39 pm
Assertio Therapeutics Announces Sale of Gralise® for Total Transaction Value of $127.5 Million - Dec 12th, 2019 12:50 pm
ASRT vs. PCRX: Which Stock Should Value Investors Buy Now? - Dec 10th, 2019 4:40 pm
Assertio Therapeutics to Present at the 31st Annual Piper Jaffray Healthcare Conference - Nov 26th, 2019 7:29 pm
Assertio Therapeutics to Present at the 2019 Stifel Healthcare Conference - Nov 13th, 2019 5:58 pm
PDL BioPharma (PDLI) Q3 Earnings Beat, LENSAR Drives Sales - Nov 7th, 2019 4:26 pm
Assertio (ASRT) Surpasses Q3 Earnings Estimates - Nov 7th, 2019 12:45 am
Assertio Therapeutics Announces Third-Quarter 2019 Results - Nov 6th, 2019 9:05 pm
How Much Did Assertio Therapeutics, Inc.'s (NASDAQ:ASRT) CEO Pocket Last Year? - Nov 4th, 2019 11:05 am
Ceridian HCM Holding, BJ's Wholesale Club Holdings Set to Join S&P MidCap 400; Oceaneering International, Covetrus to Join S&P SmallCap 600 - Oct 30th, 2019 10:35 pm
Analysts Estimate Assertio (ASRT) to Report a Decline in Earnings: What to Look Out for - Oct 30th, 2019 2:34 pm
Assertio Therapeutics to Report Third-Quarter 2019 Financial Results After the Close of Markets on Wednesday, November 6, 2019 - Oct 23rd, 2019 1:05 pm
The Daily Biotech Pulse: Biogen Alzheimer's Program Back On Track, Novartis Reports Strong Quarter, Takeda In-Licenses Autoimmune Disorder Drug - Oct 22nd, 2019 11:51 am
Assertio Therapeutics Provides Regulatory Update on Long-Acting Cosyntropin - Oct 21st, 2019 1:05 pm
The Week Ahead In Biotech: FDA Decisions, Johnson & Johnson Among Big Pharma Earnings - Oct 13th, 2019 8:33 pm
How Does Assertio Therapeutics, Inc. (NASDAQ:ASRT) Affect Your Portfolio Volatility? - Oct 5th, 2019 1:54 pm
Assertio Therapeutics Announces Appointment of Dr. David Wheadon to its Board of Directors - Sep 30th, 2019 4:35 pm
Assertio Therapeutics to Present at the Annual Cantor Fitzgerald Global Healthcare Conference - Sep 26th, 2019 12:00 pm
Medicenna Strengthens Board of Directors by Appointment of Seasoned Biopharma Executive Ms. Karen Dawes - Sep 24th, 2019 9:38 pm